N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
|
|
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Eigenschaften
- pka
- -1.73±0.40(Predicted)
Sicherheit
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Chemische Eigenschaften,Einsatz,Produktion Methoden
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 54)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14332 | 58 |
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19552 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 |
laboratory@coreychem.com | China | 30230 | 58 |
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 |
eric@witopchemical.com | China | 23541 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3148 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 |
sale@hdimpurity.com | China | 3681 | 58 |
Guangzhou CATO Research Chemicals Inc. | +86-020-81960175-617 +8615602392859 |
Intermediate@cato-chem.com | China | 6428 | 58 |
Runte International Trade Limited | 19565631292 |
lucky@sdruntechem.com | China | 300 | 58 |
Moxin Chemicals | +8617320513646 |
Anna@molcoo.com | China | 9882 | 58 |
2028267-73-2()Verwandte Suche:
- 3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile)
- Tofacitinib-23
- Tofacitinib impurity 17/Tofacitinib N-Oxide/N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)
- Azilsartan medoxomil impurity334
- Tofacitib related impurities 8
- N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
- Tofacitinib N-Oxide
- N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide (Tofacitinib Impurity)
- N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
- 3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile)
- 2028267-73-2
- 2036282-73-2